Stock·NYSE·Healthcare
Novo Nordisk A/S (NVO)
- Market cap
- $170.61B
- P/E
- 9.45
- Dividend yield
- 4.79%
- Street target
- $42.09median of 14 analysts
- 52-week range
- $35.12 $64.16
NVO stock forecast today
Where NVO stands today, and what CleaRank Financial AI makes of it.
NVO at a glance
Novo Nordisk A/S (NVO): Hold, 44/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($41.65 and $44.50).
- Valuation P/E of 9.5 against 31.9 for the Healthcare sector: a discount to peers (-70%).
Figures as of October 27, 2026.
CleaRank Financial AI
Novo Nordisk A/S (NVO) carries a CleaRank rating of Hold and a model score of 44/100.
Valuation is the biggest contributor: the P/E of 9.45 is 70.4% below the sector median, a discount to peers. The trend pulls the score down most. The price sits 13.09% below the 200-day average and 7.15% below the 50-day average, and that 50-day average is 6.40% under the 200-day. Those averages stand at $41.65 and $44.50, and over the past year the price fell 26.89%.
Only on CleaRank
Figures we compute ourselves from NVO's own price, earnings and insider-filing history. Tap one to see it in context.
NVO stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $38.67 is 7.2% below the 50-day simple moving average of $41.65.Price above its 200-day average ›
The price is 13.1% below the 200-day simple moving average of $44.50.50-day average above the 200-day ›
The 50-day average ($41.65) is 6.4% below the 200-day average ($44.50), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 12% of its 52-week range, between $35.12 and $64.16.
NVO share price
Pick a period: each tab shows how far NVO has moved over it, to the last close.
Today's trading
Where NVO sits inside today's range and its 52-week range.
NVO fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 9.45 is 70.4% below the Healthcare median of 31.9.P/S below the sector median ›
The price-to-sales ratio of 3.45 is 1.6% above the sector median of 3.4.Profitable over the last 12 months ›
Net income over the last 12 months was $17.5B on revenue of $49.4B, a net margin of 35.3%.Pays a dividend ›
The trailing dividend yield is 4.79%, or $1.85 a share a year.
Key statistics
The headline figures for NVO.
As of October 27, 2026, NVO trades at $38.67, with a market value of $170.61B, a P/E ratio of 9.45 and a dividend yield of 4.79%.
What the numbers say
CleaRank Financial AI's reading of NVO's valuation, growth and risks.
NVO trades at 9.45 times earnings, compared with a Healthcare median of 31.9. That makes it a discount to peers, with the P/E 70.4% below the sector median. On sales, the P/S of 3.45 sits 1.5% above the sector median of 3.4. Trailing earnings stand at $4.09 a share.
NVO grew revenue 2.10% in the latest quarter year on year, a pace that is 6.0 percentage points slower than the Healthcare sector median of 8.1%. Margins are strong: the net margin is 35.35% and the operating margin is 42.54%. Return on equity is 59.82%, which is above the sector median of 7.3%. Debt-to-equity stands at 0.63, and the trailing dividend yield is 4.79%, or $1.85 a share per year.
Normal swings for NVO run at about 2.02% a day; measured against the S&P 500, its beta is 0.38. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 39.73% below its 52-week high of $64.16.
NVO against the Healthcare sector
How NVO compares with the median Healthcare stock CleaRank tracks.
Price to earnings vs sector: NVO trades at a notable discount to sector peers (-70%), which may indicate undervaluation or specific company headwinds.
Return vs XLV: Since May 14, 2025, NVO has lost 39.3% against a gain of 39.2% for XLV.
Performance against XLV
NVO and the Healthcare sector fund over the same days.
Revenue and earnings
How much NVO sells, and how much of it becomes profit.
Profitable: NVO earned DKK 102B in FY2025.
NVO AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 43.1, in neutral territory.RSI above 50 ›
An RSI of 43.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of NVO
The score, the reasoning behind it, and what could move the price next.
Novo Nordisk A/S (NVO) is trading at $38.67, which leaves it below both of its main moving averages. The price sits 7.15% under the 50-day average of $41.65 and 13.09% under the 200-day average of $44.50. Sitting at 12% of its 52-week range, NVO is 10.11% above the 52-week low of $35.12. The averages point the same way, with the 50-day 6.40% below the 200-day.
The recent returns all show a loss, with the price down 24.12% over the past three months, 6.07% over the past six months and 26.89% over the past year. The price fell 1.18% in the last session on volume 55.8% above its average. On momentum, the 14-day RSI reads 43.1, in the neutral zone, with the MACD line negative.
Analyst downgrade ›
Morgan Stanley downgraded it to Underweight from Equal-Weight on September 11, 2026.
Source: Analyst action, Morgan Stanley, September 11, 2026
Rating reaffirmed ›
BMO Capital kept its Market Perform rating on October 12, 2026.
Source: Analyst action, BMO Capital, October 12, 2026
- The two levels closest to the price are the 20-day EMA at $39.11, sitting above it, and the 52-week low at $35.12, sitting below.
- A 14-day RSI of 43.1 is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
NVO stays in a downtrend for as long as it trades below both its 50-day average of $41.65 and its 200-day average of $44.50. A close back above the 50-day average would be the first sign of a repair. Overhead, the 20-day EMA at $39.11 is the first level the price would have to clear.
The next level below the price is the 52-week low at $35.12. The 14-day RSI reads 43.1, which places it in the neutral zone between 40 and 60.
Technical indicators
Momentum and trend for NVO, from its daily closes.
As of October 27, 2026, with NVO at $38.67, its 14-day RSI is 43.1 (neutral territory), its 50-day simple moving average is $41.65 and its 200-day is $44.50.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What NVO moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, NVO's 1-year correlation of daily returns is +0.26 with S&P 500 (SPY), +0.20 with Nasdaq 100 (QQQ), +0.29 with Bitcoin (BTC) and +0.06 with gold (XAU).
NVO price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
3 of 14 analysts rate it a buy or strong buy, 10 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $42.09 is 8.9% above the price.More buy ratings than three months ago ›
3 of 14 rate it a buy now, against 4 of 14 three months ago.
NVO Wall Street View
12-month price targets
The price, $38.67, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | BMO Capital | Maintains | Market Perform |
| Sep 11, 2026 | Morgan Stanley | Downgrade | Underweight |
As of October 27, 2026, 14 Wall Street analysts cover NVO: 3 rate it a buy or strong buy, 10 a hold and 1 a sell or strong sell. Their 12-month price targets range from $39.78 to $61.85. The median NVO price target is $42.09, 8.9% above the price of $38.67.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
NVO trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NVO trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NVO's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NVO tends to move, against the market and on its own.
NVO price history and drawdowns
NVO's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 2.02% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 74.8%, from June 2024 to March 2026; the price is still 71.6% below that peak.Most 1-year holds ended higher ›
72% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $23,768, against $42,015 in the S&P 500 (SPY).
NVO Drawdowns & Recovery
As of October 27, 2026, NVO's worst peak-to-trough fall over the last 10 years with dividends reinvested was -74.8% (June 2024 to March 2026); it is still 71.6% below that peak, and 72% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NVO in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NVO trailed the S&P 500 over this period: $23,768 against $42,015.
A $10,000 investment in NVO in October 2016 would be worth about $23,768 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NVO, and which have not.
Strongest month, August: an average of +5.63%, up in 7 of 10 years.
Weakest month, September: an average of -2.82%, up in 3 of 10 years.
This month, October: has averaged -0.63%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NVO's strongest calendar month has been August (average +5.63%, up in 7 of 10 years) and its weakest September (average -2.82%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
NVO stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NVO, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in NVO today could grow to about $12,848 by 2030 in the base case, with a 90th-percentile outcome near $30,129 and a 10th-percentile outcome around $5,479. The simulation models price only; at today's 4.79% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NVO Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $49.68 for NVO by 2030 in the base case, from $38.67 today (1.3x over 4 years). The 10th-percentile path ends near $21.19. These are outcomes of a Monte Carlo simulation run on NVO's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $26.88 | $41.17 | $63.05 | |
| 2028 | $23.99 | $43.83 | $80.08 | |
| 2029 | $22.31 | $46.67 | $97.63 | |
| 2030 | $21.19 | $49.68 | $117 |
Method: a lognormal simulation of NVO's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
NVO stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.